跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,583 条关于
“HBG1/2”
全部
64,583
临床试验
42,012
药物
7,320
机构
1,387
资讯
13,864
去年
Beam Therapeutics' ESCAPE Platform Shows Promise in Non-Genotoxic Conditioning for Sickle Cell Disease
3个月前
CorrectSequence's Base-Editing Therapy CS-206 Shows 15-Month VOC-Free Success in Sickle Cell Disease Patient
去年
Beam Therapeutics to Present Updated BEAM-101 Data from 17 Sickle Cell Disease Patients at EHA 2025
去年
Beam Therapeutics' BEAM-101 Shows Promise in Sickle Cell Disease Trial
去年
Editas Medicine Achieves 90% LDL Cholesterol Reduction with EDIT-401 Gene Therapy in Preclinical Studies
去年
Sickle Cell Disease Patient Death in Beam Therapeutics' BEACON Trial Highlights Conditioning Regimen Risks
去年
Beam Therapeutics Receives FDA Orphan Drug Designation for BEAM-101 Sickle Cell Disease Therapy
9个月前
Beam Therapeutics Reports Promising Long-Term Data for Base-Edited Sickle Cell Therapy Risto-cel
去年
CorrectSequence Therapeutics Achieves First Successful Sickle Cell Disease Treatment in China Using Base Editing Technology CS-101
去年
BEAM-101 Demonstrates Promising Results in Sickle Cell Disease Trial
第 1 页,共 1387 页
上一页
下一页